Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23457,95,1.30 [0.61-2.80],0.4985242365865898
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",24098,180,0.80 [0.45-1.39],0.4243711865546624
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23863,1166,0.93 [0.74-1.16],0.5000529806680736
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Candidiasis,24126,417,1.04 [0.72-1.51],0.8262714466865897
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23375,3054,0.97 [0.84-1.11],0.6127588745275296
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23586,2490,1.04 [0.89-1.20],0.6435826422115869
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23875,1179,1.14 [0.92-1.42],0.2385109760145638
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,24029,81,1.15 [0.50-2.67],0.738066455867066
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22533,706,1.15 [0.87-1.53],0.325536022776669
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21768,803,1.15 [0.89-1.50],0.2884973062893463
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,21816,222,1.38 [0.83-2.29],0.2116573625813892
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16919,1434,1.17 [0.95-1.42],0.1345561071960816
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21619,320,1.21 [0.80-1.84],0.3710066690429613
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,24066,1370,1.04 [0.85-1.28],0.7008630187329072
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Mycoses,24180,471,0.90 [0.64-1.28],0.5706096690005316
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23525,828,0.92 [0.71-1.19],0.521944597440593
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,24134,772,1.12 [0.85-1.46],0.4222234676041513
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22876,180,0.80 [0.46-1.40],0.4392790010410332
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,24238,39,1.75 [0.53-5.78],0.3610577590217253
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Other septicaemia,24048,686,1.15 [0.86-1.53],0.3508060861247849
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,24022,74,0.72 [0.30-1.73],0.4634131476087991
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Other viral diseases,24154,169,1.02 [0.57-1.83],0.9380795238179518
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",24139,154,0.95 [0.52-1.75],0.8780605742257883
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22993,296,1.20 [0.77-1.85],0.4258883825054715
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22923,226,0.92 [0.56-1.52],0.7448961734178174
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22798,102,0.81 [0.39-1.70],0.5824727403947881
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,24216,35,1.75 [0.50-6.09],0.3793175885850055
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,24169,143,0.79 [0.42-1.49],0.4651546084706045
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Viral warts,24069,43,0.55 [0.18-1.75],0.3153827509077808
PI16,Peptidase inhibitor 16,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],24097,71,0.66 [0.27-1.61],0.3567398547004241
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign lipomatous neoplasm,23991,209,0.78 [0.46-1.31],0.3475789297794109
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,24145,62,1.22 [0.46-3.20],0.6933884298353135
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,24138,60,0.76 [0.29-1.99],0.5739045873020485
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23980,1070,0.70 [0.55-0.88],0.0022829073573553
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm of meninges,24213,75,1.18 [0.49-2.83],0.7182870600156197
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24177,60,0.59 [0.22-1.57],0.2954257787301937
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,24206,115,0.47 [0.24-0.94],0.0317269561873055
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm of ovary,24167,150,0.82 [0.44-1.53],0.5337450138284836
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm: Ascending colon,24218,243,0.96 [0.59-1.56],0.8722197193474891
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm: Caecum,24224,224,0.50 [0.31-0.83],0.0067167310135678
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",24158,60,1.23 [0.47-3.21],0.6781413814843391
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm: Descending colon,24222,133,0.99 [0.52-1.91],0.9859516477673008
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm: Rectum,24183,245,1.22 [0.75-1.98],0.4278669972354081
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,24136,450,0.88 [0.62-1.26],0.4988194565982582
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Benign neoplasm: Transverse colon,24223,256,0.92 [0.57-1.47],0.7214782730674595
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Carcinoma in situ of breast,19605,119,1.08 [0.53-2.19],0.8384282878745408
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19678,139,1.33 [0.69-2.57],0.39347843206569
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",19671,31,1.70 [0.43-6.77],0.4540500654305817
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",19697,57,1.26 [0.46-3.43],0.6520864693777964
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",24175,127,0.38 [0.19-0.73],0.0038549914737257
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Haemangioma, any site",24176,125,0.37 [0.19-0.73],0.003814158589969
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Leiomyoma of uterus,23354,511,0.55 [0.39-0.77],0.0005315582690489
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Lung cancer and mesothelioma,17405,288,0.67 [0.42-1.06],0.0842547497816824
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Lymphoid leukaemia,19675,35,1.63 [0.44-5.96],0.4630679319647213
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19794,154,3.11 [1.67-5.82],0.0003693530384364
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",19739,99,1.40 [0.65-3.02],0.3846274641346807
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19809,169,0.83 [0.46-1.47],0.5184512175944141
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",19703,63,1.35 [0.52-3.53],0.5358244817244482
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",19704,64,0.53 [0.21-1.35],0.1812894644344572
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",19689,49,1.92 [0.65-5.70],0.2394719336940102
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19769,129,1.97 [1.00-3.87],0.0488038207482459
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",19734,94,1.21 [0.56-2.64],0.6262960197840546
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",19715,75,1.00 [0.41-2.42],0.9996114363523028
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",19676,36,0.41 [0.12-1.42],0.1600550094472765
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,19711,71,1.75 [0.70-4.35],0.2303993299499999
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Melanocytic naevi,24003,207,1.39 [0.81-2.38],0.2340966160925315
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Melanocytic naevi of trunk,24198,70,2.78 [1.10-7.04],0.0311248940769616
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Melanoma in situ,19669,77,0.64 [0.27-1.53],0.3158312026113861
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",19712,72,1.08 [0.44-2.64],0.8638031440701792
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19775,135,0.76 [0.40-1.46],0.4124651612615753
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",19850,210,0.71 [0.43-1.19],0.1936569212699108
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",19723,83,0.87 [0.38-2.01],0.7499685716437334
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,Other benign neoplasms of skin,24040,154,0.96 [0.52-1.78],0.8995079871635133
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",20457,817,1.61 [1.23-2.11],0.0005273250949577
PI16,Peptidase inhibitor 16,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",20493,853,1.73 [1.33-2.26],4.165182695919662e-05
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23953,343,1.26 [0.84-1.90],0.2637234679029687
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22477,86,2.51 [1.11-5.66],0.026318335800828
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23681,71,1.63 [0.67-3.98],0.2808850070860161
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23341,2607,1.02 [0.88-1.18],0.8411623873748117
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22812,28,0.85 [0.21-3.48],0.8162890990296224
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23887,46,1.59 [0.53-4.79],0.4106098170296836
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23722,1331,1.05 [0.86-1.30],0.6141639298489548
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23722,1331,1.05 [0.86-1.30],0.6141639298489548
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22458,67,2.27 [0.90-5.77],0.0841483466952204
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23871,1087,0.93 [0.74-1.17],0.5619074984359829
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23943,102,1.61 [0.76-3.41],0.2100879007236908
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23656,46,1.17 [0.38-3.55],0.7828768186847714
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23664,54,0.94 [0.34-2.56],0.8977249923997699
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,24050,209,1.95 [1.16-3.29],0.0124274719757176
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,24141,53,0.54 [0.19-1.51],0.242681541831043
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",24019,178,2.13 [1.21-3.76],0.009097700048734
PI16,Peptidase inhibitor 16,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22898,114,0.89 [0.44-1.80],0.749962251896813
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,19550,212,1.35 [0.81-2.26],0.2548653119975784
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22980,60,0.67 [0.39-1.16],0.1558794185066151
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22977,57,0.42 [0.15-1.13],0.0867601980921652
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,19381,43,1.10 [0.34-3.57],0.8681932273406526
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22231,55,0.70 [0.26-1.89],0.4768379509794849
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21939,207,0.84 [0.50-1.42],0.5174083239395982
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23850,421,0.87 [0.60-1.25],0.4388942552340282
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23690,261,0.76 [0.48-1.22],0.2590245771199611
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,23489,60,0.50 [0.19-1.31],0.1573814359846402
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23897,1721,1.06 [0.88-1.27],0.522987653983915
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21497,1684,1.02 [0.85-1.22],0.8549236138574761
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",19385,47,1.56 [0.51-4.77],0.432406491383798
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",21549,103,0.77 [0.36-1.62],0.4860171340634056
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,19590,252,0.72 [0.45-1.16],0.1731015698157108
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,19381,43,0.58 [0.18-1.88],0.3677134614732368
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22099,2761,0.84 [0.73-0.97],0.0206800046264829
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,19524,186,0.84 [0.48-1.46],0.5375253162247304
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,19822,484,0.73 [0.52-1.02],0.0689015015867562
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,24149,314,1.10 [0.72-1.68],0.6642739568896885
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23981,146,1.09 [0.59-2.02],0.7882227134152269
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,19429,91,0.88 [0.40-1.96],0.7599151186154777
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",19387,49,1.95 [0.65-5.84],0.2305321645328624
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23466,2020,0.90 [0.76-1.06],0.2087913174560033
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,19516,178,1.56 [0.89-2.74],0.1221683508867697
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,19511,173,2.98 [1.68-5.28],0.0001828078024876
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19806,468,0.95 [0.67-1.35],0.7901646988256723
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,19409,71,1.19 [0.48-2.91],0.7068992147353179
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23975,140,1.09 [0.58-2.04],0.7990553445302306
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,19880,542,0.79 [0.57-1.09],0.1488274063651811
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,19824,486,0.83 [0.59-1.18],0.2987931060271026
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21796,64,1.50 [0.58-3.87],0.4058392031715184
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23464,4126,0.87 [0.77-0.98],0.0192279949882729
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,21512,66,0.64 [0.25-1.60],0.3380777809025751
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,21525,79,0.40 [0.17-0.93],0.0342654968445706
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,24068,1804,0.78 [0.66-0.93],0.0058588606106756
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",24072,1803,0.78 [0.66-0.93],0.0060588685580487
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,21519,73,0.78 [0.33-1.88],0.5827992911573063
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23874,1394,1.08 [0.88-1.32],0.4632209311854036
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20648,1310,0.91 [0.74-1.13],0.3999752135879932
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,24227,157,1.81 [1.01-3.26],0.0477376610789113
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,23469,40,0.47 [0.15-1.51],0.205617715097785
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22600,120,2.28 [1.14-4.54],0.0195075541890721
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22651,171,0.53 [0.30-0.93],0.02679829389838
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",19555,217,0.97 [0.57-1.63],0.8998378955441807
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22620,121,1.70 [0.87-3.34],0.1233319308729651
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1511,38,2.05 [0.64-6.57],0.227717952740288
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1606,152,1.69 [0.95-3.02],0.0760333871654991
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22523,24,8.29 [1.77-38.78],0.0072177058427363
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1495,23,10.00 [2.22-45.15],0.0027514767200687
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23816,1317,0.64 [0.52-0.79],1.803019688455952e-05
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23723,294,0.65 [0.42-1.00],0.0526465743548499
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,22153,421,0.88 [0.61-1.26],0.475241379905053
PI16,Peptidase inhibitor 16,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19966,628,1.00 [0.74-1.35],0.983374800715966
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",24149,208,1.44 [0.86-2.43],0.1665462387265967
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23335,45,0.77 [0.25-2.35],0.6507860278111787
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Angina pectoris,22892,762,0.84 [0.64-1.10],0.2133322909986159
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Aortic aneurysm,23371,81,1.34 [0.58-3.08],0.4967602512164971
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23320,30,3.59 [0.92-14.00],0.0655620013956848
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",23429,139,1.08 [0.57-2.03],0.8146243122385688
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,15743,1279,0.78 [0.63-0.97],0.0222595866760712
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,AV-block,21261,213,0.65 [0.39-1.08],0.0979395826989261
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",24196,266,0.71 [0.45-1.13],0.1503459352092282
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Cardiac arrest,14573,109,0.78 [0.38-1.63],0.513390917277238
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Cardiomyopathy,21167,119,0.71 [0.36-1.43],0.3393419073015206
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",21119,71,0.39 [0.16-0.96],0.0408794767048552
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,24234,28,0.81 [0.44-1.47],0.4852552115804407
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Conduction disorders,21688,640,1.01 [0.75-1.36],0.967041099836393
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23429,1309,0.90 [0.73-1.11],0.3375631613759948
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21810,6424,0.78 [0.70-0.85],1.7374466854780086e-07
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22920,221,1.36 [0.82-2.26],0.2332547222725421
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Endocarditis,21095,47,1.78 [0.58-5.43],0.3136991881622113
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Heart failure, strict",24154,733,0.85 [0.65-1.12],0.2584996479657381
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Hypertension,22361,5404,0.72 [0.65-0.80],1.056936301623419e-09
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Hypertension, essential",22369,5412,0.73 [0.66-0.81],2.006283500681388e-09
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Hypertension, portal",24133,37,1.08 [0.32-3.65],0.9055514564200668
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",17112,155,1.02 [0.55-1.88],0.9447768363351938
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,17024,67,7.56 [2.98-19.17],2.0214971919763515e-05
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Hypotension,24118,933,1.13 [0.88-1.45],0.3250972788856379
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23568,85,1.44 [0.64-3.25],0.3757226082706844
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23611,1481,0.90 [0.74-1.09],0.274748482082165
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23959,403,0.63 [0.43-0.91],0.0136926370364791
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Left bundle-branch block,21318,270,1.01 [0.64-1.60],0.9661243287550324
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,24044,535,1.14 [0.83-1.58],0.4223402653546901
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22558,428,1.29 [0.90-1.85],0.1720899246061007
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",24213,77,1.34 [0.57-3.16],0.5054329056975873
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",24230,211,1.65 [0.99-2.77],0.0563448151525653
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Oesophageal varices,22734,35,1.55 [0.43-5.50],0.5010787264658927
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other aneurysm,23339,49,2.35 [0.79-6.97],0.1245243063833677
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other arrhythmias,21366,318,0.76 [0.49-1.16],0.2013357173494626
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23351,61,2.92 [1.13-7.56],0.0270739734207335
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23464,174,2.10 [1.19-3.70],0.010879308494797
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,21196,148,1.01 [0.54-1.89],0.9653284782092716
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other disorders of veins,22775,76,1.39 [0.59-3.28],0.4530945855004094
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22741,42,1.42 [0.44-4.59],0.5548610755857777
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,23136,32,0.71 [0.19-2.68],0.6117889613248946
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22836,137,1.16 [0.61-2.22],0.6432274381618154
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21729,681,0.72 [0.54-0.96],0.0244149926789277
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23223,38,3.18 [0.93-10.79],0.0641287206287375
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23740,450,1.01 [0.71-1.44],0.9632546064344454
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23723,292,0.71 [0.46-1.10],0.1247836283781741
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23575,471,0.73 [0.52-1.03],0.0718235577212166
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14716,252,0.56 [0.35-0.91],0.0197446456295845
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23524,245,1.47 [0.91-2.37],0.1122018673891568
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22988,289,1.28 [0.82-2.00],0.2690037047591632
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23822,391,1.39 [0.95-2.04],0.0872441951434745
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,24165,506,1.09 [0.78-1.52],0.6013042392385547
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Right bundle-branch block,21237,189,1.42 [0.81-2.48],0.2179123899074288
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23716,285,0.73 [0.47-1.12],0.1503317363452308
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,23239,135,1.13 [0.60-2.16],0.7015353696072955
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23950,467,0.75 [0.53-1.05],0.0967576521670951
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23926,509,0.86 [0.62-1.19],0.3646051388911349
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23537,64,3.13 [1.23-7.96],0.0166300464086615
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23326,36,1.27 [0.35-4.55],0.7133953523151473
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23744,188,0.85 [0.49-1.46],0.5489420404506669
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23687,178,0.77 [0.44-1.34],0.3610973018622695
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Varicose veins,23086,387,1.47 [1.00-2.16],0.0504179005895371
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23299,83,1.15 [0.51-2.60],0.744090505547077
PI16,Peptidase inhibitor 16,Chapter IX Diseases of the circulatory system,Venous thromboembolism,24050,617,1.42 [1.05-1.92],0.0238148597925537
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",24200,199,0.45 [0.26-0.76],0.0029571310680331
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21552,1627,0.99 [0.82-1.20],0.9237504670327136
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,Any mental disorder,23710,3785,0.94 [0.83-1.06],0.3001318729184411
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",24174,237,0.44 [0.27-0.72],0.0010245428391049
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21665,1740,1.03 [0.86-1.24],0.7365450555344792
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20003,78,0.57 [0.25-1.33],0.195989982956349
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,Smoking dependency,23875,1049,0.90 [0.72-1.13],0.3731761217066954
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21143,1218,0.85 [0.69-1.06],0.1496160666921582
PI16,Peptidase inhibitor 16,Chapter V Mental and behavioural disorders,Vascular dementia,23811,94,0.92 [0.43-1.97],0.8225220878668373
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Alzheimer disease,24236,322,0.77 [0.51-1.16],0.2124777040044481
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",16610,51,1.52 [0.53-4.35],0.4352854434680413
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Bell's palsy,22344,71,2.04 [0.83-5.03],0.1197667151621056
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22832,559,1.01 [0.74-1.40],0.9327576444312904
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Cerebral cysts,23886,191,0.77 [0.45-1.33],0.3548642257638463
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,24170,240,1.15 [0.71-1.86],0.5693137807475331
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23814,38,0.37 [0.11-1.21],0.0988942795032474
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,24225,44,0.88 [0.29-2.74],0.8318979139158338
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23740,45,0.53 [0.17-1.61],0.2620862709549117
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Epilepsy,22953,247,1.51 [0.93-2.45],0.0981787145349542
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23866,1160,1.13 [0.91-1.41],0.2751523612823702
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,24193,309,0.96 [0.62-1.47],0.8444069950396382
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23690,2539,0.97 [0.84-1.13],0.6868820092262493
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Generalized epilepsy,23914,41,0.90 [0.28-2.89],0.8658796030785083
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Hemiplegia,24122,192,1.22 [0.71-2.09],0.4687749892045454
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Hydrocephalus,23751,56,3.95 [1.45-10.76],0.0072898548147323
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,24218,67,1.74 [0.69-4.39],0.2388307305675792
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22386,113,0.79 [0.38-1.61],0.51361391347423
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22327,54,0.84 [0.30-2.35],0.7434144736745603
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Memory loss,23699,95,0.85 [0.39-1.84],0.6739565086948605
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Migraine,23147,441,1.43 [0.99-2.06],0.0566829668389777
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",24135,399,1.42 [0.97-2.09],0.0729612532092585
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Motor neuron disease,16700,116,0.71 [0.35-1.43],0.3390449469145279
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,24034,129,1.25 [0.63-2.45],0.5246984664933405
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23501,1228,1.00 [0.81-1.24],0.9819634231637364
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Neurological diseases,22810,3259,0.95 [0.83-1.09],0.4598717194599658
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23900,124,0.87 [0.45-1.71],0.6956694350874706
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22650,377,1.22 [0.83-1.81],0.3099851397820469
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",24185,199,1.46 [0.86-2.48],0.1609541442328973
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19606,581,0.79 [0.58-1.08],0.1414193972961335
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23755,60,0.85 [0.32-2.24],0.7438373058037474
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23806,111,1.12 [0.55-2.27],0.7547614784833382
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,24026,142,0.89 [0.48-1.68],0.7267644473197259
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22352,79,1.94 [0.82-4.55],0.1302204593431131
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Other headache syndromes,22772,66,0.84 [0.33-2.12],0.7088268295911019
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Other neurological diseases,24136,441,0.95 [0.67-1.36],0.7876323644363566
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Other sleep disorders,23057,351,0.74 [0.50-1.11],0.1491910294331583
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Parkinson's disease,24213,146,1.11 [0.60-2.07],0.7398346879309895
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23768,73,0.48 [0.20-1.17],0.1084702944793975
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Restless leg syndrome,24235,76,0.92 [0.39-2.18],0.8554490554765126
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Sleep apnoea,24080,281,0.74 [0.47-1.15],0.1762985033300791
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Small fibre neuropathy,24020,34,1.11 [0.30-4.04],0.8789800741596557
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,24226,140,0.66 [0.35-1.25],0.2047495277063354
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22335,62,0.60 [0.23-1.56],0.2971800931180314
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,24236,325,0.78 [0.51-1.18],0.2324761266053679
PI16,Peptidase inhibitor 16,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23772,91,1.12 [0.51-2.45],0.7754646383525639
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23717,94,0.92 [0.43-2.00],0.8427908306617826
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23834,427,0.72 [0.50-1.04],0.0773224683914981
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,24109,143,1.07 [0.58-1.97],0.8210965678247721
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23258,53,0.50 [0.18-1.42],0.1961052742546709
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23253,48,0.76 [0.25-2.33],0.6348109254268182
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",24125,58,0.90 [0.34-2.38],0.826369529262548
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23982,147,0.98 [0.53-1.82],0.952199247636036
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1502,29,9.69 [2.56-36.66],0.0008172755963575
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1795,56,3.04 [1.19-7.76],0.0202227858781146
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23707,84,0.70 [0.31-1.60],0.4036332286838892
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,24086,927,0.94 [0.74-1.21],0.6384791322723526
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23863,658,0.68 [0.51-0.91],0.0105078129462348
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23471,266,0.81 [0.51-1.29],0.3705335674501946
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",24161,754,0.84 [0.64-1.10],0.2099434302409314
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,24225,63,1.27 [0.49-3.28],0.62553306938897
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,24093,686,0.77 [0.58-1.02],0.0722031112002427
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",24197,362,0.89 [0.60-1.32],0.5654130773496522
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,24151,185,1.09 [0.63-1.90],0.746075414483294
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23243,38,2.35 [0.68-8.05],0.1750865919126225
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23248,43,0.48 [0.15-1.49],0.2021358973157263
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23266,61,1.13 [0.43-2.99],0.8082210839543218
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,24157,627,0.86 [0.64-1.16],0.335378535963846
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23684,154,0.75 [0.41-1.37],0.353833898077148
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23465,58,0.96 [0.36-2.57],0.9354613602014282
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23926,91,0.64 [0.29-1.42],0.2737332470003606
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,24115,280,0.95 [0.60-1.48],0.8106497628412285
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23591,184,0.89 [0.51-1.56],0.6906156112728113
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,24086,120,1.34 [0.67-2.66],0.407814991024205
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23938,408,1.03 [0.71-1.49],0.8769112732351194
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23760,137,0.89 [0.47-1.69],0.72449432895758
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22654,2240,0.74 [0.63-0.87],0.0002115493520238
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,24080,245,0.91 [0.56-1.46],0.6856816182792647
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,24215,144,1.59 [0.84-2.98],0.1513098719560763
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23543,338,0.65 [0.43-0.99],0.0423995316025813
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23894,59,0.49 [0.19-1.28],0.14561482634095
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,24212,50,1.33 [0.46-3.87],0.5959010972478277
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23288,83,1.64 [0.71-3.76],0.2441336430813656
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23335,130,0.68 [0.35-1.33],0.2600150218770498
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,23253,94,1.18 [0.54-2.57],0.6726975061079736
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23465,58,3.25 [1.19-8.82],0.0209608317936055
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",23218,59,0.77 [0.29-2.06],0.6012364939256661
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23635,105,0.82 [0.40-1.71],0.6026472686723303
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23687,157,0.74 [0.41-1.34],0.3222256094056379
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23316,111,0.58 [0.29-1.18],0.1351198154304354
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,23243,84,0.89 [0.38-2.07],0.7818921301772065
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,23220,61,1.64 [0.63-4.29],0.3144863477117422
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22249,1835,0.70 [0.59-0.83],6.11813041232728e-05
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23283,78,1.45 [0.61-3.43],0.4013735801360782
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,24004,381,0.74 [0.50-1.08],0.1193513582973871
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23663,40,1.25 [0.39-4.03],0.7135041424987925
PI16,Peptidase inhibitor 16,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23771,148,1.16 [0.63-2.16],0.6315595249453723
PI16,Peptidase inhibitor 16,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,24008,102,1.05 [0.50-2.21],0.8955040454252572
PI16,Peptidase inhibitor 16,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,24194,95,1.14 [0.52-2.49],0.7391675607972317
PI16,Peptidase inhibitor 16,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,24125,128,1.03 [0.53-2.01],0.930636518043709
PI16,Peptidase inhibitor 16,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23971,65,1.72 [0.68-4.38],0.255374832378072
PI16,Peptidase inhibitor 16,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,23973,67,1.07 [0.42-2.73],0.8847781262392883
PI16,Peptidase inhibitor 16,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,24141,707,1.00 [0.75-1.32],0.9811034677225774
PI16,Peptidase inhibitor 16,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23917,483,1.03 [0.73-1.45],0.8661340526434174
PI16,Peptidase inhibitor 16,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23535,101,0.81 [0.39-1.71],0.5858935041920539
PI16,Peptidase inhibitor 16,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,23511,77,0.70 [0.30-1.64],0.4068932857004574
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Acute pharyngitis,23986,75,0.49 [0.21-1.15],0.1020409165582897
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,24122,211,0.70 [0.42-1.19],0.1872076165749706
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23969,58,1.80 [0.66-4.88],0.2478382896654343
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,All influenza,22735,114,1.63 [0.81-3.29],0.173685364131344
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22734,113,1.70 [0.84-3.43],0.1423343038445473
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Allergic asthma (mode),17231,114,0.31 [0.15-0.62],0.0011028459652392
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Allergic rhinitis,24113,250,0.64 [0.39-1.03],0.0657547785394376
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18800,1845,0.60 [0.50-0.72],2.9606160799444583e-08
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18938,1821,0.61 [0.51-0.73],6.614595221545887e-08
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23872,116,1.16 [0.58-2.31],0.6835275093197137
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22683,62,0.87 [0.34-2.23],0.7666581984772544
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Bronchiectasis,20934,356,0.67 [0.45-1.00],0.049545577382244
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20640,62,0.47 [0.18-1.24],0.1262991186820923
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23214,2636,0.68 [0.59-0.79],3.203480883903935e-07
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",23109,58,0.57 [0.21-1.54],0.2644982567555776
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Chronic sinusitis,23179,128,0.79 [0.40-1.55],0.4935311940645895
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",24082,913,0.65 [0.51-0.84],0.0007129043708449
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Deviated nasal septum,23118,67,0.84 [0.33-2.14],0.7175799980691058
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22378,4538,0.78 [0.70-0.88],2.5617376565034385e-05
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23351,300,1.06 [0.68-1.64],0.7940957241685278
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Early onset COPD,23454,285,0.95 [0.61-1.48],0.8332075697695422
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Emphysema,20812,234,0.63 [0.39-1.04],0.071292529585254
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22747,207,1.22 [0.72-2.06],0.4548716097181091
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Influenza and pneumonia,24056,1435,1.08 [0.89-1.32],0.4245811166644092
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Interstitial lung disease,22784,244,1.16 [0.71-1.87],0.5544882682776495
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Later onset COPD,23410,628,0.59 [0.44-0.80],0.0005351137121374
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,24230,192,0.72 [0.42-1.24],0.2410590081920156
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Nasal polyp,23112,61,0.44 [0.17-1.14],0.0915073410975866
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,24028,827,1.01 [0.78-1.31],0.9493655145003886
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Other diseases of pleura,24065,1539,0.97 [0.80-1.17],0.727639374595331
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23747,696,0.75 [0.56-1.00],0.0489418884265998
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Other pleural conditions,22561,35,0.49 [0.14-1.76],0.2737382425295298
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,24160,308,1.19 [0.78-1.82],0.4249587754375005
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,24155,1049,1.01 [0.80-1.28],0.90628953668549
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Pleural effusion,23258,732,0.85 [0.64-1.12],0.2552961548197374
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Pleural plaque,22567,41,0.93 [0.29-3.02],0.9062612768554644
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23840,1219,1.11 [0.89-1.37],0.3625363248946115
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,24202,164,0.65 [0.36-1.17],0.1495692520369771
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Pneumothorax,22614,88,0.51 [0.23-1.13],0.0963638752417794
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Pollen allergy,24216,211,0.55 [0.33-0.94],0.0271936120948784
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Pulmonary oedema,23906,54,1.58 [0.58-4.32],0.3719192256446654
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Respiratory insufficiency,17161,44,0.37 [0.12-1.12],0.0791093457558381
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,24009,808,1.03 [0.79-1.34],0.8286850812956398
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,23301,250,0.63 [0.39-1.02],0.0624881040476615
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Viral pneumonia,22807,186,0.87 [0.50-1.50],0.6123990131027883
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23879,146,0.73 [0.40-1.35],0.3185642934798524
PI16,Peptidase inhibitor 16,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11682,91,1.79 [0.80-4.00],0.1567811174189573
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,17342,35,0.72 [0.20-2.58],0.6188838870236739
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Acute appendicitis,24063,123,1.09 [0.54-2.20],0.803102697025213
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Acute gastritis,18198,74,1.85 [0.76-4.49],0.1728911586094079
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Acute pancreatitis,22212,143,0.99 [0.53-1.86],0.9870388648675756
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Acute peritonitis,23725,74,4.47 [1.89-10.60],0.000664725270232
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23470,33,0.76 [0.42-1.38],0.3682637557364094
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Barrett oesophagus,18432,308,1.17 [0.76-1.80],0.4858543739447261
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22142,73,1.24 [0.52-2.96],0.6299603282462587
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23860,73,1.26 [0.53-3.03],0.5991763472969303
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Cholecystitis,22227,158,0.90 [0.50-1.62],0.7183778216215673
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Cholelithiasis,23126,1057,0.74 [0.59-0.93],0.0113486678976142
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Chronic gastritis,18420,296,0.94 [0.60-1.46],0.7853682309183379
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22105,36,4.37 [1.26-15.20],0.020326658689842
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",24164,68,1.19 [0.49-2.93],0.6987434694351411
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Coeliac disease,22883,128,0.62 [0.32-1.22],0.1698186945264522
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Collagenous colitis,22557,95,1.70 [0.77-3.74],0.1855679740590893
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,24111,142,0.58 [0.31-1.10],0.0932240901573334
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Constipation,23939,1494,0.92 [0.76-1.12],0.414577546034632
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Crohn disease,22536,74,1.63 [0.66-3.99],0.2876699440706651
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23912,51,1.06 [0.37-3.08],0.9126935477578114
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22538,76,1.65 [0.68-3.99],0.2698379487403548
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Dental caries,23506,203,0.63 [0.37-1.07],0.0866941440280289
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22787,2147,0.94 [0.80-1.11],0.4930338276041039
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Diseases of appendix,24102,162,0.94 [0.51-1.73],0.8482639630082791
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Diseases of liver,24148,711,0.83 [0.62-1.09],0.1805299638669955
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22201,4077,0.91 [0.81-1.02],0.1172957124514401
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23823,520,0.89 [0.64-1.24],0.4946563368939995
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Diseases of peritoneum,24125,474,1.19 [0.84-1.68],0.3346728064770292
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23407,104,1.19 [0.57-2.50],0.639588623488216
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Diseases of salivary glands,23277,57,0.63 [0.23-1.71],0.367495269341804
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23976,1221,0.96 [0.77-1.19],0.6855006768081537
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Diseases of tongue,23279,93,1.02 [0.46-2.26],0.9522391365586512
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23479,1410,0.80 [0.66-0.98],0.032977083201555
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20128,2821,0.85 [0.74-0.98],0.0272276890692059
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Duodenal ulcer,18243,119,0.61 [0.30-1.21],0.155657393281237
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",24187,99,0.63 [0.30-1.34],0.2330600680100326
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,24151,57,0.67 [0.24-1.87],0.4408893161495414
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23522,85,0.92 [0.41-2.06],0.8404461259113518
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,17411,104,0.73 [0.35-1.55],0.414279927104654
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Functional dyspepsia,18712,588,0.88 [0.64-1.20],0.4123161662245763
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Gastric ulcer,18433,309,0.85 [0.55-1.30],0.4495222241091355
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20578,2454,0.82 [0.70-0.96],0.0109746443206945
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18548,424,0.76 [0.53-1.10],0.1438462085264751
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18953,7415,0.91 [0.83-1.00],0.0395317088689566
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,GI-bleeding,23730,975,1.02 [0.80-1.30],0.8822600961619791
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,23364,61,1.93 [0.73-5.08],0.1849862869467278
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,18164,1116,0.87 [0.69-1.09],0.2194592721094745
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23471,34,1.91 [0.54-6.77],0.3171102190976483
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Hernia,23178,2538,0.95 [0.82-1.11],0.5402143807027333
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Impacted teeth,24159,52,0.58 [0.20-1.71],0.3248099284723094
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Impaction of intestines,17366,59,0.89 [0.33-2.35],0.8066454443458694
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Inguinal hernia,20794,154,0.92 [0.50-1.71],0.8007183460119697
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,17393,86,1.21 [0.53-2.73],0.6531644474601722
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22910,155,0.73 [0.40-1.35],0.3141915750973405
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18020,713,1.06 [0.80-1.41],0.6959580894775697
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,24225,306,0.52 [0.34-0.80],0.0027759780330484
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23185,723,1.05 [0.79-1.40],0.7169229439580813
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23427,965,1.03 [0.81-1.32],0.8095766936280602
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Oesophageal obstruction,18258,134,0.55 [0.29-1.07],0.0767427567907048
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Oesophagitis,18634,510,0.90 [0.65-1.26],0.5510697190081276
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,24194,142,0.62 [0.33-1.17],0.1380022991912265
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20694,54,0.88 [0.32-2.45],0.8093337900919951
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,18415,1108,0.89 [0.71-1.12],0.3360673724404503
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22332,263,0.76 [0.48-1.21],0.2460961521901087
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22236,167,0.95 [0.53-1.70],0.8698051781025505
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of intestine,18701,1394,0.84 [0.69-1.03],0.0955208605563227
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of intestines,22319,5012,0.93 [0.83-1.03],0.1678365774237205
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23278,205,0.59 [0.35-1.01],0.0532819585114587
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of liver,24028,591,0.80 [0.59-1.09],0.1578075323022078
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18653,529,0.94 [0.68-1.31],0.7289309331249236
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22206,137,1.67 [0.88-3.16],0.1179698399986408
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,24068,417,0.98 [0.68-1.42],0.9167586300903088
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19075,951,0.86 [0.67-1.10],0.2216017621256419
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23746,991,1.02 [0.80-1.30],0.8562691258226309
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23459,156,1.06 [0.58-1.94],0.8620009446364862
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18853,1546,0.90 [0.74-1.09],0.2694672504026381
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19973,1849,1.03 [0.86-1.23],0.7646548390522196
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23530,93,1.47 [0.67-3.21],0.3343772774371358
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23315,853,1.07 [0.82-1.38],0.632852473881969
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17601,294,1.05 [0.68-1.63],0.8309382317796259
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,24142,66,0.76 [0.29-1.98],0.5722130148065265
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17743,436,0.96 [0.67-1.38],0.844926410695146
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22877,122,1.28 [0.65-2.54],0.4761964479394507
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Recurring oral aphthae,24228,65,1.98 [0.77-5.07],0.1567673163363177
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,23305,118,1.65 [0.82-3.34],0.1620824870607412
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Toxic colitis,22517,55,0.63 [0.23-1.72],0.3641028264829121
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18335,211,0.93 [0.55-1.56],0.7801184371134287
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Ulcerative colitis,22613,151,0.90 [0.48-1.67],0.7379010107234727
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22590,128,0.72 [0.37-1.42],0.3453992550739967
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Umbilical hernia,20794,154,0.88 [0.48-1.62],0.6921509449828049
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,17476,169,0.94 [0.53-1.66],0.8210968862842765
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Ventral hernia,20864,224,1.30 [0.79-2.15],0.2984141733218537
PI16,Peptidase inhibitor 16,Chapter XI Diseases of the digestive system,Volvulus,17381,74,0.65 [0.27-1.56],0.3364951259127609
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,24161,221,0.83 [0.50-1.39],0.4848680526628302
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23950,76,0.77 [0.33-1.84],0.56078647596956
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22412,196,1.25 [0.72-2.17],0.4202604516315509
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23756,554,1.27 [0.92-1.75],0.1445993667225548
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23336,134,0.75 [0.39-1.43],0.377815952472375
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22501,285,1.10 [0.71-1.71],0.6716352392154017
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23955,249,0.71 [0.44-1.15],0.1650878410348897
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,24136,430,0.88 [0.61-1.26],0.4804648886835285
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23752,46,1.10 [0.36-3.41],0.8634875828638657
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22819,2804,0.91 [0.79-1.05],0.1961321225000479
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23838,413,0.72 [0.50-1.05],0.0889645950162317
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23709,284,0.81 [0.52-1.28],0.3717614126256079
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23950,748,1.05 [0.80-1.38],0.7420390325567559
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",24217,68,0.33 [0.13-0.82],0.0167889028207099
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,22304,88,0.66 [0.30-1.46],0.3018415598211439
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23464,39,0.32 [0.10-1.03],0.0558385150902637
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23941,235,0.73 [0.45-1.19],0.2097287707858254
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22591,375,0.94 [0.63-1.39],0.7441029754490233
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,22264,48,0.79 [0.26-2.38],0.6798543352134825
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,24144,69,1.19 [0.48-2.91],0.70831181966813
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,23336,134,1.30 [0.68-2.49],0.4261149898574857
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,24025,151,0.49 [0.27-0.89],0.020162081839526
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23750,44,1.28 [0.42-3.92],0.660341827138893
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,22274,58,0.47 [0.18-1.26],0.1329230174493202
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23635,1419,1.03 [0.85-1.26],0.7494148699564791
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22622,406,0.90 [0.61-1.31],0.5800615887611775
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,22268,52,0.69 [0.24-1.97],0.489039547474837
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,24159,285,0.58 [0.37-0.90],0.0149492613570728
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23781,75,1.85 [0.77-4.43],0.167055453238054
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,24094,220,0.63 [0.38-1.04],0.0700264910548525
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,24188,248,0.85 [0.52-1.39],0.5223652302778674
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22358,142,1.72 [0.90-3.29],0.1016653344740771
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22450,234,1.35 [0.82-2.22],0.243081818875894
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,24176,236,0.84 [0.51-1.38],0.4921333286573626
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",22394,178,1.67 [0.96-2.92],0.069531801490099
PI16,Peptidase inhibitor 16,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,24203,128,0.89 [0.46-1.73],0.7341664039979346
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20688,119,0.86 [0.43-1.74],0.675383560092059
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,22014,5643,0.91 [0.82-1.00],0.0614498303359828
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20780,4409,0.90 [0.81-1.01],0.0800276511910867
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20635,66,1.07 [0.41-2.75],0.8951757409704986
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20789,139,1.72 [0.91-3.28],0.0976634131644811
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20835,185,1.31 [0.75-2.30],0.3412471796892655
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23984,102,1.23 [0.58-2.62],0.5822815756070754
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20754,104,0.79 [0.38-1.65],0.5321609189163059
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17592,1221,0.88 [0.71-1.10],0.2591307157386245
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",24095,201,0.94 [0.56-1.60],0.8267132529715923
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21169,519,0.71 [0.51-0.98],0.0393125612635254
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20368,7194,0.94 [0.86-1.03],0.2061097251970118
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21702,124,1.24 [0.63-2.44],0.5423121880269661
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20690,121,0.49 [0.25-0.96],0.0382052419522863
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21179,610,0.90 [0.66-1.22],0.4970540255946877
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23327,2677,0.89 [0.77-1.02],0.1009629497213173
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20727,158,0.65 [0.35-1.19],0.1629198665975939
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20913,344,0.94 [0.62-1.42],0.7729897436407807
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20724,155,0.56 [0.30-1.04],0.0684146138508472
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23358,93,0.88 [0.40-1.94],0.7570924129500056
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18029,1658,0.96 [0.80-1.16],0.7029247099779666
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16555,184,0.80 [0.46-1.39],0.4386659549447746
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",24223,181,0.92 [0.54-1.59],0.7776388121577561
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16466,95,0.66 [0.30-1.46],0.3049407980311828
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16883,512,1.41 [1.00-1.98],0.0516136609403381
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20868,299,0.97 [0.62-1.51],0.9022453946814796
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16927,556,1.01 [0.73-1.40],0.9442605111545078
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20709,59,0.89 [0.33-2.37],0.8095306836605842
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21284,634,0.93 [0.69-1.25],0.6257373902285426
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20946,296,1.23 [0.79-1.91],0.3686217960864104
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16888,517,0.94 [0.67-1.31],0.7000696613427915
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20643,74,0.86 [0.36-2.07],0.7328103077816943
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20631,62,1.19 [0.45-3.15],0.7194619619889244
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,21624,46,0.93 [0.31-2.84],0.9019065698921616
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23819,2241,1.12 [0.96-1.32],0.1619902057647705
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23191,1613,1.03 [0.85-1.24],0.7659544542290102
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",24051,526,0.86 [0.62-1.20],0.3771253406203244
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19063,2692,0.87 [0.75-1.01],0.0659846873156698
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,16432,61,1.36 [0.51-3.67],0.5393750551063081
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20661,92,0.99 [0.45-2.20],0.9857448177053172
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,16413,42,0.83 [0.26-2.69],0.7551336399225086
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16554,183,0.68 [0.38-1.20],0.1828148552523915
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21841,263,1.09 [0.68-1.75],0.7165229890661737
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22084,506,0.95 [0.68-1.34],0.7845542869194353
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,24212,97,1.55 [0.72-3.35],0.2603482750359381
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22454,1804,0.92 [0.77-1.10],0.3563570944022597
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20683,114,0.90 [0.44-1.85],0.773343070772713
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16579,208,1.78 [1.04-3.04],0.0353356264223374
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21366,716,0.98 [0.74-1.30],0.8753783347627516
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18624,2253,1.03 [0.88-1.21],0.6936405878515235
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23380,115,1.01 [0.50-2.05],0.97617601142761
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,24218,75,0.75 [0.31-1.79],0.5173647608587292
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20637,68,1.62 [0.65-4.08],0.3022425773715868
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21875,1306,0.95 [0.77-1.17],0.6221770579633716
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20642,73,0.42 [0.17-1.00],0.050217111547383
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18139,1768,0.76 [0.63-0.91],0.002613198539813
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21708,130,0.71 [0.36-1.38],0.3091525160731824
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20619,50,2.00 [0.67-6.00],0.2170802793646709
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20827,177,0.74 [0.42-1.30],0.290114386572577
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21080,511,0.96 [0.69-1.33],0.7911755675391681
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23717,452,0.69 [0.49-0.99],0.0422438646696363
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21219,569,1.16 [0.85-1.58],0.3609183760793405
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,24063,509,0.80 [0.58-1.12],0.1995081272014582
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,24211,59,0.64 [0.24-1.69],0.3642338917360289
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20766,197,0.97 [0.56-1.68],0.922521307953098
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18583,809,0.92 [0.70-1.20],0.5285999635547363
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21160,591,0.96 [0.70-1.31],0.8002171991414601
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20679,110,0.79 [0.38-1.64],0.5293970244815556
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16446,75,0.80 [0.33-1.92],0.6167491329336827
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18717,2346,0.79 [0.68-0.93],0.0034593006080103
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,17111,740,0.76 [0.58-1.01],0.060869800131129
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23525,260,0.67 [0.42-1.07],0.0965118396698301
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",24186,71,2.13 [0.87-5.20],0.0981052835609589
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",22214,49,0.67 [0.23-1.92],0.4555853667293975
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,16447,76,0.68 [0.28-1.63],0.3883721151052746
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20750,100,2.01 [0.94-4.30],0.073059037405455
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16901,530,0.77 [0.55-1.07],0.1192409904790698
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20855,286,1.06 [0.68-1.66],0.7904013637616244
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20904,254,0.83 [0.52-1.34],0.4467569864653604
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20896,246,0.75 [0.46-1.21],0.2387302104009993
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18691,78,1.40 [0.59-3.34],0.4502220710774991
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",24217,65,0.74 [0.29-1.89],0.5290990038994252
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21134,565,1.05 [0.76-1.44],0.7771028982136998
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],23412,147,0.89 [0.47-1.66],0.7055382386022708
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,23070,2501,0.94 [0.81-1.09],0.4206203727564012
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20709,140,0.61 [0.32-1.16],0.1303297491227447
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21141,491,0.86 [0.61-1.21],0.3834584616980596
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22674,230,0.76 [0.46-1.25],0.2786449871725376
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20871,221,0.71 [0.43-1.18],0.1847824588518289
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22183,1533,0.90 [0.74-1.09],0.2598831956262695
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21692,1042,0.94 [0.74-1.19],0.6049514135816896
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20626,57,1.34 [0.49-3.67],0.5659619290600041
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23482,217,0.99 [0.59-1.65],0.9666431401264004
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20746,177,1.24 [0.70-2.20],0.4648337272691525
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20687,118,0.66 [0.33-1.32],0.2361768199441668
PI16,Peptidase inhibitor 16,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),16417,46,1.51 [0.49-4.66],0.4690951360183479
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Acute renal failure,23379,1049,1.43 [1.13-1.80],0.0025444533224515
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),18118,87,0.80 [0.35-1.84],0.6061025699247526
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23622,100,1.01 [0.47-2.20],0.9747053747691716
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,24094,201,0.53 [0.31-0.89],0.0168718403416234
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23915,22,0.76 [0.16-3.74],0.7391305792846818
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23505,1175,2.95 [2.37-3.68],5.094647462331828e-22
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,24092,60,11.97 [4.74-30.26],1.5459221029481837e-07
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,24061,207,1.13 [0.67-1.91],0.6397193169299713
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Cystitis,21409,221,0.80 [0.48-1.34],0.4002773470460853
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Dialysis,22375,45,1.95 [1.24-3.06],0.0037558584687233
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23811,289,1.05 [0.67-1.64],0.8347772068964248
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Endometriosis,18182,151,0.83 [0.44-1.56],0.5677365621052308
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18376,345,0.73 [0.48-1.12],0.14782173162108
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18912,881,0.58 [0.45-0.75],3.389055501935284e-05
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18825,4369,0.93 [0.83-1.05],0.240903417413304
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,24085,53,4.03 [1.46-11.17],0.007317096808036
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,22206,182,1.13 [0.64-1.99],0.6729739103152829
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23747,350,0.77 [0.51-1.16],0.2094147887861354
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Irregular menses,23824,110,0.58 [0.27-1.23],0.1548853986088584
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18301,270,0.73 [0.45-1.18],0.1950901524520885
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,21256,68,1.11 [0.44-2.79],0.8284006472855037
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,20185,2154,0.70 [0.59-0.82],1.706651443679912e-05
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,18153,122,0.68 [0.34-1.37],0.2810086813443664
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",24227,57,0.91 [0.33-2.47],0.8502211360858924
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",24227,72,0.67 [0.28-1.60],0.3625897715698228
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23134,1946,0.95 [0.80-1.12],0.5304969239967199
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21606,418,0.71 [0.49-1.03],0.0698285820571116
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23624,102,1.22 [0.57-2.59],0.6043964883122055
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,24184,330,1.17 [0.77-1.77],0.4594193413323905
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,24183,79,0.38 [0.16-0.87],0.0229776889884526
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22856,1668,0.99 [0.83-1.19],0.9429086544964046
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23577,180,0.92 [0.52-1.62],0.7765554178239434
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,18168,137,0.79 [0.41-1.51],0.4667971089855978
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",18377,346,0.70 [0.46-1.05],0.081757294365385
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,18134,103,0.69 [0.32-1.46],0.3334616968048569
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,18214,183,0.70 [0.40-1.23],0.212636996020191
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22253,229,1.30 [0.78-2.16],0.3104966492670423
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23963,109,1.06 [0.51-2.17],0.879957913362453
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,18294,263,0.87 [0.54-1.40],0.5632762141274428
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,18124,93,0.39 [0.17-0.86],0.0191050836788116
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18599,568,0.75 [0.54-1.03],0.0728230723017574
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,18172,141,0.76 [0.40-1.43],0.394209819522321
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18554,523,0.65 [0.46-0.90],0.0096254305492103
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,24066,34,5.55 [1.56-19.73],0.0080643742589754
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,24079,2055,1.76 [1.49-2.08],2.6432315894348274e-11
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",22171,147,2.37 [1.25-4.49],0.0079139397547005
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22414,84,4.79 [2.08-11.04],0.0002315729590507
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23925,32,1.56 [0.41-5.96],0.5130116969825
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Urethral stricture,21317,129,0.71 [0.37-1.38],0.313093552926616
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Urolithiasis,24125,232,0.60 [0.37-0.98],0.039847542312835
PI16,Peptidase inhibitor 16,Chapter XIV Diseases of the genitourinary system,Uterine polyps,18154,123,0.38 [0.19-0.75],0.0051364435978586
